by University of California, Los AngelesCredit: Pixabay/CC0 Public DomainIn a new translational study from UCLA Jonsson Comprehensive Cancer Center, researchers analyzed genetic changes in the or
by University of California, Los AngelesCredit: Pixabay/CC0 Public DomainIn a new translational study from UCLA Jonsson Comprehensive Cancer Center, researchers analyzed genetic changes in the or
by University of BristolCredit: CC0 Public DomainDiabetic patients who take anti-diabetic drugs—known as glitazones—long term had a lower risk of primary and secondary brain cancer compared with
by University of BristolCredit: CC0 Public DomainDiabetic patients who take anti-diabetic drugs—known as glitazones—long term had a lower risk of primary and secondary brain cancer compared with
by Stacy Pigott,University of ArizonaOn the left, cells isolated from breast cancer cells were treated with RANKL, a growth factor that stimulates bone resorption, to produce osteoclasts (pink).
by Stacy Pigott,University of ArizonaOn the left, cells isolated from breast cancer cells were treated with RANKL, a growth factor that stimulates bone resorption, to produce osteoclasts (pink).
by Hunter Medical Research InstituteTumor response, PFS, and OS. A, Spider plot of tumor burden change of target lesions in reference to the baseline tumor burden in 18 patients with measurable t
by Hunter Medical Research InstituteTumor response, PFS, and OS. A, Spider plot of tumor burden change of target lesions in reference to the baseline tumor burden in 18 patients with measurable t
by University of CologneTumor samples and clinical history of 65 patients with SCLC. a, Tumor sites sampled from 65 patients with SCLC. Frequently sampled sites are highlighted in bold. Tumors we
by University of CologneTumor samples and clinical history of 65 patients with SCLC. a, Tumor sites sampled from 65 patients with SCLC. Frequently sampled sites are highlighted in bold. Tumors we
byUniversity of Chicago Medical CenterCredit: Pixabay/CC0 Public DomainResults of a multicenter phase II clinical trial led by the University of Chicago Medicine Comprehensive Cancer Center show
byUniversity of Chicago Medical CenterCredit: Pixabay/CC0 Public DomainResults of a multicenter phase II clinical trial led by the University of Chicago Medicine Comprehensive Cancer Center show
by West Virginia UniversityAccording to the American Cancer Society, about 45,000 Americans will have died from pancreatic cancer by year's end. That's more than the number projected to d
by West Virginia UniversityAccording to the American Cancer Society, about 45,000 Americans will have died from pancreatic cancer by year's end. That's more than the number projected to d
by Cleveland ClinicCredit: CC0 Public DomainCleveland Clinic researchers have shown for the first time that diet-associated molecules in the gut are associated with aggressive prostate cancer, su
by Cleveland ClinicCredit: CC0 Public DomainCleveland Clinic researchers have shown for the first time that diet-associated molecules in the gut are associated with aggressive prostate cancer, su
by Perelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainKnocking out a protein known to stifle T cell activation on CAR T cells using the CRISPR/Cas9 technology e
by Perelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainKnocking out a protein known to stifle T cell activation on CAR T cells using the CRISPR/Cas9 technology e
byUTSouthwestern Medical CenterSummary of our findings on Trp dependency and vulnerability in MYC-driven tumors. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-478
byUTSouthwestern Medical CenterSummary of our findings on Trp dependency and vulnerability in MYC-driven tumors. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-478
by Delthia Ricks , Medical XpressEndoscopic photographs of lesions in three false-negative patients. Credit:Science Translational Medicine(2024). DOI: 10.1126/scitranslmed.adk5395Artificia
by Delthia Ricks , Medical XpressEndoscopic photographs of lesions in three false-negative patients. Credit:Science Translational Medicine(2024). DOI: 10.1126/scitranslmed.adk5395Artificia